Summary Of: Saxagliptin

Encyclodia Page On: Saxagliptin

These Are Links To Other Documents

| IUPAC | CAS number | ATC code | PubChem | Formula | C | H | N | O | Mol. mass | g | mol | Bioavailability | Metabolism | Half life | Excretion | Pregnancy cat. | Legal status | Routes | rINN | anti-diabetic drug | dipeptidyl peptidase-4 (DPP-4) inhibitor | Bristol-Myers Squibb | clinical trials | type 2 diabetes mellitus | blood glucose | GIP | GLP-1 | Otsuka Pharmaceutical Co. | AstraZeneca | dipeptidyl peptidase 4 | Development of dipeptidyl peptidase-4 inhibitors | Journal of Medicinal Chemistry | doi | European Journal of Biochemistry | Press release | Banting and Best Diabetes Centre at UT | | pharmacology | stub | v | d | Oral antidiabetic drugs | Insulin analogs | A10 | Insulin sensitizers | Biguanides | Metformin | Buformin | Phenformin | TZDs | PPAR | Pioglitazone | Rivoglitazone | Rosiglitazone | Troglitazone | Secretagogues | Sulfonylureas | 1st generation | Carbutamide | Chlorpropamide | Gliclazide | Tolbutamide | Tolazamide | 2nd generation | Glipizide | Glibenclamide (Glyburide) | Gliquidone | Glyclopyramide | 3rd generation | Glimepiride | Meglitinides | Nateglinide | Repaglinide | Mitiglinide | GLP-1 | Exenatide | Liraglutide | DPP-4 inhibitors | Alogliptin | Linagliptin | Sitagliptin | Vildagliptin | Alpha-glucosidase inhibitors | Acarbose | Miglitol | Voglibose | Amylin | Pramlintide | Experimental | Dual PPAR agonists | Aleglitazar | Muraglitazar | Tesaglitazar | SGLT2 | Dapagliflozin | Remogliflozin | Sergliflozin | Insulin analogs | Insulin lispro | Insulin aspart | Insulin glulisine | Insulin glargine | Insulin detemir | Inhalable insulin (Exubera) | clinical trials | Withdrawn | Development | Categories | Pharmacology stubs | Dipeptidyl peptidase-4 inhibitors | Nitriles | Bristol-Myers Squibb |